How I manage priapism in chronic myeloid leukaemia patients

British Journal of Haematology

Volumn 158, Issue 2, 2012, Pages 155-164

  Rodgers, Ryan ^a   Latif, Zak ^b   Copland, Mhairi ^a,c  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Chronic myeloid leukaemia; Erectile dysfunction; Intracavernous therapy; Leukapheresis; Priapism

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALLOPURINOL; ANDROGEN RECEPTOR ANTAGONIST; BACLOFEN; DASATINIB; DIETHYLSTILBESTROL; EPHEDRINE; ETILEFRINE; GONADORELIN AGONIST; HYDROXYUREA; IMATINIB; LOW MOLECULAR WEIGHT HEPARIN; METARAMINOL; NILOTINIB; NITRIC OXIDE; PHENYLEPHRINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTAGLANDIN E1; PROTEIN TYROSINE KINASE INHIBITOR; SILDENAFIL; TERBUTALINE; VASOACTIVE AGENT;

ASPIRATION; BLOOD GAS ANALYSIS; BLOOD PRESSURE MONITORING; BRADYCARDIA; CANCER STAGING; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; ELECTROCARDIOGRAPHY MONITORING; ERECTILE DYSFUNCTION; GYNECOMASTIA; HEART ARRHYTHMIA; HEART PALPITATION; HORMONAL THERAPY; HUMAN; HYPERTENSION; HYPERVISCOSITY SYNDROME; ISCHEMIC PRIAPISM; LABORATORY DIAGNOSIS; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOSTASIS; LUNG EMBOLISM; MALE; MEDICAL HISTORY; MONOTHERAPY; PATHOPHYSIOLOGY; PENIS ERECTION; PENIS PROSTHESIS; PRIAPISM; PRIORITY JOURNAL; RADIODIAGNOSIS; RARE DISEASE; REVIEW; SHUNTING; SIGNAL TRANSDUCTION; STUTTERING PRIAPISM; TACHYCARDIA; TESTOSTERONE BLOOD LEVEL; THROMBOEMBOLISM; URETHRA FISTULA;

ANTINEOPLASTIC AGENTS; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PENILE ERECTION; PENIS; PRIAPISM;

EID: 84863487234     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09151.x     Document Type: Review

References (76)

1. Adams, B.D., Baker, R., Lopez, J.A. & Spencer, S. (2009) Myeloproliferative disorders and the hyperviscosity syndrome. Emergency Medicine Clinics of North America, 27, 459-476.
2. Ahmed, I. & Shaikh, N.A. (1997) Treatment of intermittent idiopathic priapism with oral terbutaline. British Journal of Urology, 80, 341.
3. Allue Lopez, M., Garcia de Jalon Martinez, A., Pascual Regueiro, D., Mallen Mateo, E., Villanueva Benedicto, A. & Rioja Sanz, L.A. (2004) [Priapism as an initial presentation of chronic myeloid leukaemia]. Actas Urologicas Espanolas, 28, 387-389.
4. Aversa, A. & Sarteschi, L.M. (2007) The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med, 4, 1437-1447.
5. Bartram, C.R., de Klein, A., Hagemeijer, A., van Agthoven, T., Geurts van Kessel, A., Bootsma, D., Grosveld, G., Ferguson-Smith, M.A., Davies, T., Stone, M., Heisterkamp, N., Stephenson, J.R. & Groffen, J. (1983) Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature, 306, 277-280.
6. Bastuba, M.D., Saenz de Tejada, I., Dinlenc, C.Z., Sarazen, A., Krane, R.J. & Goldstein, I. (1994) Arterial priapism: diagnosis, treatment and long-term followup. Journal of Urology, 151, 1231-1237.
7. Becker, H.C., Pralle, H. & Weidner, W. (1985) Therapy of priapism in high counting myeloid leukemia-a combined oncological-urological approach. Two case reports. Urologia Internationalis, 40, 284-286.
8. Bivalacqua, T.J., Liu, T., Musicki, B., Champion, H.C. & Burnett, A.L. (2007) Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. European Urology, 51, 1732-1740.
9. Bosch, R.J., Benard, F., Aboseif, S.R., Stief, C.G., Lue, T.F. & Tanagho, E.A. (1991) Penile detumescence: characterization of three phases. Journal of Urology, 146, 867-871.
10. Burnett, A.L., Bivalacqua, T.J., Champion, H.C. & Musicki, B. (2006) Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. Journal of Sexual Medicine, 3, 1077-1084.
11. Castagnetti, M., Sainati, L., Giona, F., Varotto, S., Carli, M. & Rigamonti, W. (2008) Conservative management of priapism secondary to leukemia. Pediatric Blood & Cancer, 51, 420-423.
12. Cervantes, F. & Mauro, M. (2011) Practical management of patients with chronic myeloid leukemia. Cancer, 117, 4343-4354.
13. Champion, H.C., Bivalacqua, T.J., Takimoto, E., Kass, D.A. & Burnett, A.L. (2005) Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proceedings of the National Academy of Sciences of the United States of America, 102, 1661-1666.
14. Chaux, A., Amin, M., Cubilla, A.L. & Young, R.H. (2011) Metastatic tumors to the penis: a report of 17 cases and review of the literature. International Journal of Surgical Pathology, 19, 597-606.
15. Cherian, J., Rao, A.R., Thwaini, A., Kapasi, F., Shergill, I.S. & Samman, R. (2006) Medical and surgical management of priapism. Postgraduate Medical Journal, 82, 89-94.
16. Dean, R.C. & Lue, T.F. (2005) Physiology of penile erection and pathophysiology of erectile dysfunction. Urologic Clinics of North America, 32, 379-395.v.
17. Eland, I.A., van der Lei, J., Stricker, B.H. & Sturkenboom, M.J. (2001) Incidence of priapism in the general population. Urology, 57, 970-972.
18. Emond, A.M., Holman, R., Hayes, R.J. & Serjeant, G.R. (1980) Priapism and impotence in homozygous sickle cell disease. Archives of Internal Medicine, 140, 1434-1437.
19. Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R. & Kantarjian, H.M. (1999) The biology of chronic myeloid leukemia. New England Journal of Medicine, 341, 164-172.
20. Fowler, J.E., Jr, Koshy, M., Strub, M. & Chinn, S.K. (1991) Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. Journal of Urology, 145, 65-68.
21. Gogia, A., Sharma, A., Raina, V. & Gupta, R. (2012) Priapism as an initial presentation of chronic lymphocytic leukemia. Leukaemia & Lymphoma, E-pub Feb 13; DOI 10.3109/10428194.2012.656636.
22. Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R. & Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 36, 93-99.
23. Gupta, S., Salimpour, P., Saenz de Tejada, I., Daley, J., Gholami, S., Daller, M., Krane, R.J., Traish, A.M. & Goldstein, I. (1998) A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. Journal of Urology, 159, 1529-1536.
24. Gupta, A., Seth, T. & Gupta, A. (2009) Successful use of terbutaline in persistent priapism in a 12-year-old boy with chronic myeloid leukemia. Pediatric Hematology and Oncology, 26, 70-73.
25. Hamre, M.R., Harmon, E.P., Kirkpatrick, D.V., Stern, M.J. & Humbert, J.R. (1991) Priapism as a complication of sickle cell disease. Journal of Urology, 145, 1-5.
26. Hinman, F. (1914) Priapism: report of cases and a clinical study of the literature with reference to its pathogenesis and surgical treatment. Annals of Surgery, 60, 689-716.
27. Hinman, F., Jr (1960) Priapism; reasons for failure of therapy. Journal of Urology, 83, 420-428.
28. Hinman, F., Jr, Donley, S. & Stempen, P.H. (1998) Atlas of Urologic Surgery. WB Saunders, Philadelphia.
29. Hiwase, D.K., Yeung, D.T. & White, D.L. (2011) Optimizing the selection of kinase inhibitors for chronic myeloid leukemia patients. Experts Reviews of Hematology, 4, 285-299.
30. Ilkay, A.K. & Levine, L.A. (1995) Conservative management of high-flow priapism. Urology, 46, 419-424.
31. Jameel, T. & Mehmood, K. (2009) Priapism - An unusual presentation in chronic myeloid leukaemia: case report and review of the literature. Biomedica, 25, 197-199.
32. Ji, M.X., He, N.S., Wang, P. & Chen, G. (1994) Use of selective embolization of the bilateral cavernous arteries for posttraumatic arterial priapism. Journal of Urology, 151, 1641-1642.
33. Kandel, G.L., Bender, L.I. & Grove, J.S. (1968) Pulmonary embolism: a complication of corpus-saphenous shunt for priapism. Journal of Urology, 99, 196-197.
34. Kanika, N.D., Tar, M., Tong, Y., Kuppam, D.S., Melman, A. & Davies, K.P. (2009) The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. American Journal of Physiology Cell Physiology, 297, C916-C927.
35. Kantarjian, H., Shah, N.P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., Nakamae, H., Huguet, F., Boque, C., Chuah, C., Bleickardt, E., Bradley-Garelik, M.B., Zhu, C., Szatrowski, T., Shapiro, D. & Baccarani, M. (2010) Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. New England Journal of Medicine, 362, 2260-2270.
36. Keoghane, S.R., Sullivan, M.E. & Miller, M.A. (2002) The aetiology, pathogenesis and management of priapism. British Journal of Urology International, 90, 149-154.
37. Leitner, A.A., Hochhaus, A. & Muller, M.C. (2011) Current treatment concepts of CML. Current Cancer Drug Targets, 11, 31-43.
38. Lomas, G.M. & Jarow, J.P. (1992) Risk factors for papaverine-induced priapism. Journal of Urology, 147, 1280-1281.
39. Lugo, T.G., Pendergast, A.M., Muller, A.J. & Witte, O.N. (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science, 247, 1079-1082.
40. Mantadakis, E., Cavender, J.D., Rogers, Z.R., Ewalt, D.H. & Buchanan, G.R. (1999) Prevalence of priapism in children and adolescents with sickle cell anemia. Journal of Pediatric Hematology/oncology, 21, 518-522.
41. Mentzel, H.J., Kentouche, K., Doerfel, C., Vogt, S., Zintl, F. & Kaiser, W.A. (2004) High-flow priapism in acute lymphatic leukaemia. Pediatric Radiology, 34, 560-563.
42. Mi, T., Abbasi, S., Zhang, H., Uray, K., Chunn, J.L., Xia, L.W., Molina, J.G., Weisbrodt, N.W., Kellems, R.E., Blackburn, M.R. & Xia, Y. (2008) Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. Journal of Clinical Investigation, 118, 1491-1501.
43. Montague, D.K., Jarow, J., Broderick, G.A., Dmochowski, R.R., Heaton, J.P., Lue, T.F., Nehra, A. & Sharlip, I.D. (2003) American Urological Association guideline on the management of priapism. Journal of Urology, 170, 1318-1324.
44. Montague, D.K., Jarow, J.P., Broderick, G.A., Dmochowski, R.R., Heaton, J.P., Lue, T.F., Milbank, A.J., Nehra, A. & Sharlip, I.D. (2005) Chapter 1: the management of erectile dysfunction: an AUA update. Journal of Urology, 174, 230-239.
45. Morano, S.G., Latagliata, R., Carmosino, I., Girmenia, C., Dal Forno, S. & Alimena, G. (2000) Treatment of long-lasting priapism in chronic myeloid leukemia at onset. Annals of Hematology, 79, 644-645.
46. Morrison, B.F. & Burnett, A.L. (2011) Priapism in hematological and coagulative disorders: an update. Nature Review Urology, 8, 223-230.
47. Mulhall, J.P. & Honig, S.C. (1996) Priapism: etiology and management. Academic Emergency Medicine, 3, 810-816.
48. Muruve, N. & Hosking, D.H. (1996) Intracorporeal phenylephrine in the treatment of priapism. Journal of Urology, 155, 141-143.
49. Nitahara, K.S. & Lue, T.F. (1998) Priapism. In: Glenn's Urologic Surgery (ed. S.D. Graham Jr, J.F. Glen & C.C. Carson). pp. 346-8. Lippincott Williams and Wilkins, Philadelphia.
50. O'Brien, S.G., Guilhot, F., Larson, R.A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J.J., Fischer, T., Hochhaus, A., Hughes, T., Lechner, K., Nielsen, J.L., Rousselot, P., Reiffers, J., Saglio, G., Shepherd, J., Simonsson, B., Gratwohl, A., Goldman, J.M., Kantarjian, H., Taylor, K., Verhoef, G., Bolton, A.E., Capdeville, R. & Druker, B.J. (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. New England Journal of Medicine, 348, 994-1004.
51. Ochoa Urdangarain, O. & Hermida Perez, J.A. (1998) Priapism. Our experience. Archivos Espanoles de Urologia, 51, 269-276.
52. Okimoto, R.A. & Van Etten, R.A. (2011) Navigating the road toward optimal initial therapy for chronic myeloid leukemia. Current Opinion in Hematology, 18, 89-97.
53. Olujohungbe, A.B., Adeyoju, A., Yardumian, A., Akinyanju, O., Morris, J., Westerdale, N., Akenova, Y., Kehinde, M.O., Anie, K., Howard, J., Brooks, A., Davis, V.A. & Khoriatry, A.I. (2011) A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial-the priapism in sickle cell study. Journal of Andrology, 32, 375-382.
54. Ponniah, A., Brown, C.T. & Taylor, P. (2004) Priapism secondary to leukemia: effective management with prompt leukapheresis. International Journal of Urology, 11, 809-810.
55. Porcu, P., Cripe, L.D., Ng, E.W., Bhatia, S., Danielson, C.M., Orazi, A. & McCarthy, L.J. (2000) Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leukaemia & Lymphoma, 39, 1-18.
56. Powell, B.L., Craig, J.B. & Muss, H.B. (1985) Secondary malignancies of the penis and epididymis: a case report and review of the literature. Journal of Clinical Oncology, 3, 110-116.
57. Priyadarshi, S. (2004) Oral terbutaline in the management of pharmacologically induced prolonged erection. International Journal of Impotence Research, 16, 424-426.
58. Pryor, J., Akkus, E., Alter, G., Jordan, G., Lebret, T., Levine, L., Mulhall, J., Perovic, S., Ralph, D. & Stackl, W. (2004) Priapism. J Sex Med, 1, 116-120.
59. Ramos, C.E., Park, J.S., Ritchey, M.L. & Benson, G.S. (1995) High flow priapism associated with sickle cell disease. Journal of Urology, 153, 1619-1621.
60. Rourke, K.F., Fischler, A.H. & Jordan, G.H. (2002) Treatment of recurrent idiopathic priapism with oral baclofen. Journal of Urology, 168, 2552, Discussion 2552-2553.
61. Rowe, J.M. & Lichtman, M.A. (1984) Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia. Blood, 63, 1230-1234.
62. Rowley, J.D. (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 290-293.
63. Saenz de Tejada, I., Ware, J.C., Blanco, R., Pittard, J.T., Nadig, P.W., Azadzoi, K.M., Krane, R.J. & Goldstein, I. (1991) Pathophysiology of prolonged penile erection associated with trazodone use. Journal of Urology, 145, 60-64.
64. Saglio, G., Kim, D.W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R.E., Hochhaus, A., Hughes, T.P., Gallagher, N., Hoenekopp, A., Dong, M., Haque, A., Larson, R.A. & Kantarjian, H.M. (2010) Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. New England Journal of Medicine, 362, 2251-2259.
65. Sattar, A.A., Salpigides, G., Vanderhaeghen, J.J., Schulman, C.C. & Wespes, E. (1995) Cavernous oxygen tension and smooth muscle fibers: relation and function. Journal of Urology, 154, 1736-1739.
66. Schreibman, S.M., Gee, T.S. & Grabstald, H. (1974) Management of priapism in patients with chronic granulocytic leukemia. Journal of Urology, 111, 786-788.
67. Serjeant, G.R. (1981) Observations on the epidemiology of sickle cell disease. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75, 228-233.
68. Shafique, S., Bona, R. & Kaplan, A.A. (2007) A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis. Therapeutic Apheresis and Dialysis, 11, 146-149.
69. Shantha, T.R., Finnerty, D.P. & Rodriquez, A.P. (1989) Treatment of persistent penile erection and priapism using terbutaline. Journal of Urology, 141, 1427-1429.
70. Spycher, M.A. & Hauri, D. (1986) The ultrastructure of the erectile tissue in priapism. Journal of Urology, 135, 142-147.
71. Steinhardt, G.F. & Steinhardt, E. (1981) Priapism in children with leukemia. Urology, 18, 604-606.
72. Stucki, A., Rivier, A.S., Gikic, M., Monai, N., Schapira, M. & Spertini, O. (2001) Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood, 97, 2121-2129.
73. Vilke, G.M., Harrigan, R.A., Ufberg, J.W. & Chan, T.C. (2004) Emergency evaluation and treatment of priapism. Journal of Emergency Medicine, 26, 325-329.
74. Virag, R., Bachir, D., Lee, K. & Galacteros, F. (1996) Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology, 47, 777-781, Discussion 781.
75. Wen, J., Jiang, X., Dai, Y., Zhang, Y., Tang, Y., Sun, H., Mi, T., Kellems, R.E., Blackburn, M.R. & Xia, Y. (2010) Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism. Journal of Sexual Medicine, 7, 3011-3022.
76. Yuan, J., Desouza, R., Westney, O.L. & Wang, R. (2008) Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian Journal of Andrology, 10, 88-101.